Molecular Features and Clinical Management of Hereditary Gynecological Cancers

Molecular Features and Clinical Management of Hereditary Gynecological Cancers

Hereditary gynecological cancers are caused by several inherited genes. Tumors that arise in the female reproductive system, such as ovaries and the uterus, overlap with hereditary cancers. Several hereditary cancer-related genes are important because they might lead to therapeutic targets. Treatmen...

Full description

Bibliographic Details
Main Authors:	Arisa Ueki, Akira Hirasawa
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Series:	International Journal of Molecular Sciences
Subjects:	hereditary gynecological cancer multi-gene testing tumor profiling hereditary breast and ovarian cancer (HBOC) Lynch Li–Fraumeni
Online Access:	https://www.mdpi.com/1422-0067/21/24/9504

Similar Items

Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool
by: Mattia Garutti, et al.
Published: (2023-04-01)

Systematic review of the molecular basis of hereditary breast and ovarian cancer syndrome in Brazil: the current scenario
by: Andreza Amália de Freitas Ribeiro, et al.
Published: (2024-03-01)

Increased Co-Occurrence of Pathogenic Variants in Hereditary Breast and Ovarian Cancer and Lynch Syndromes: A Consequence of Multigene Panel Genetic Testing?
by: Mar Infante, et al.
Published: (2022-09-01)

K3326X and Other C-Terminal BRCA2 Variants Implicated in Hereditary Cancer Syndromes: A Review
by: Scott Baughan, et al.
Published: (2021-01-01)

Breast cancer in patients with Li–Fraumeni syndrome – a case-series study and review of literature
by: Nandikolla AG, et al.
Published: (2017-03-01)

Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis
by: Muhammad Danyal Ahsan, et al.
Published: (2023-12-01)

A matched case-control study of the prognosis of early breast cancer in patients with Li-Fraumeni syndrome (BREAST TP53)
by: Vanessa Petry, et al.
Published: (2023-04-01)

Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain)
by: Ainara Ruiz de Sabando, et al.
Published: (2019-11-01)

Genetic and Preventive Services for Hereditary Breast and Ovarian Cancer in the Czech Republic
by: Foretova Lenka, et al.
Published: (2006-11-01)

From the patient to the population: Use of genomics for population screening
by: Chloe Mighton, et al.
Published: (2022-10-01)

Report on the Effect of the Implementation of an Early Detection and Prevention of Cancer Program on Families at High Hereditary Risk—Concentrating on Patients Undergoing Genetic Diagnostics and Counseling in Central Poland
by: Tadeusz Kałużewski, et al.
Published: (2023-08-01)

Validation of a digital identification tool for individuals at risk for hereditary cancer syndromes
by: Leslie Bucheit, et al.
Published: (2019-01-01)

Detection of BRCA1 Pathogenic Variant in a 24-Year-Old Endometrial Cancer Patient: Risks of Several Hereditary Tumor Syndromes Assessed Using Germline Multigene Panel Testing
by: Xiaofei Wang, et al.
Published: (2022-08-01)

Breast cancer characteristics and surgery among women with Li‐Fraumeni syndrome in Germany—A retrospective cohort study
by: Nathalie Rippinger, et al.
Published: (2021-11-01)

Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model
by: Jacopo Azzollini, et al.
Published: (2022-04-01)

Hereditary gynaecologic cancers in Nepal: a proposed model of care to serve high risk populations in developing countries
by: Hanoon P. Pokharel, et al.
Published: (2017-09-01)

Diagnostics and treatment of ovarian cancer in the era of precision medicine - opportunities and challenges
by: Patrycja Aleksandra Bukłaho, et al.
Published: (2023-09-01)

Cross-Cultural Adaptation and Validation of a French Version of the Genetic Counseling Satisfaction Scale (GCSS) as an Outcome Measure of Genetic Counseling for Hereditary Breast and Ovarian Cancer
by: Célia Villafane-Bernier, et al.
Published: (2021-09-01)

Quantitative Analysis of BRCA1 and BRCA2 Germline Splicing Variants Using a Novel RNA-Massively Parallel Sequencing Assay
by: Suzette Farber-Katz, et al.
Published: (2018-07-01)

Molecular Signature of Gynecological Malignancies: A Narrative Review
by: Samah Saharti
Published: (2022-08-01)

Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study
by: Boya Guo, et al.
Published: (2023-09-01)

Distress, anxiety, and depression in persons with hereditary cancer syndromes: Results from a nationwide cross‐sectional study in Germany
by: Anna Maria Kastner, et al.
Published: (2023-06-01)

Hereditary Colorectal Cancer in Brunei Darussalam
by: Muhammad Hazman Awang Josli, et al.
Published: (2024-01-01)

Updates in gynecologic care for individuals with lynch syndrome
by: Kaylee A. Underkofler, et al.
Published: (2023-03-01)

Breast Cancer Phenotype Associated With Li-Fraumeni Syndrome: A Brazilian Cohort Enriched by TP53 p.R337H Carriers
by: Renata Lazari Sandoval, et al.
Published: (2022-03-01)

Pancreatic cancer as a sentinel for hereditary cancer predisposition
by: Erin L. Young, et al.
Published: (2018-06-01)

Spectrum of High-Risk Mutations among Breast Cancer Patients Referred for Multigene Panel Testing in a Romanian Population
by: Iulian Gabriel Goidescu, et al.
Published: (2023-03-01)

Pathology of Hereditary Breast and Ovarian Cancer
by: Anjelica Hodgson, et al.
Published: (2020-09-01)

Occurrence of variants of unknown clinical significance in genetic testing for hereditary breast and ovarian cancer syndrome and Lynch syndrome: a literature review and analytical observational retrospective cohort study
by: Felicia Adam, et al.
Published: (2023-01-01)

Lynch syndrome as a manifestation of hereditary ovarian cancer: a case report of treatment of a patient with platinum-sensitive recurrent ovarian cancer
by: R. R. Faiskhanova, et al.
Published: (2021-06-01)

The first pancreatic neuroendocrine tumor in Li-Fraumeni syndrome: a case report
by: John G. Aversa, et al.
Published: (2020-03-01)

A novel germline mutation of TP53 with breast cancer diagnosed as Li–Fraumeni syndrome
by: Masaya Kai, et al.
Published: (2022-10-01)

HNPCC (Lynch Syndrome): Differential Diagnosis, Molecular Genetics and Management - a Review
by: Lynch Henry T, et al.
Published: (2003-12-01)

Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53
by: Meis Omran, et al.
Published: (2020-01-01)

Clinical Outcome of Hereditary Breast Cancer in the Lithuanian Population
by: Elsakov Pavel, et al.
Published: (2005-04-01)

Increased Risk of Hereditary Prostate Cancer in Italian Families with Hereditary Breast and Ovarian Cancer Syndrome Harboring Mutations in <i>BRCA</i> and in Other Susceptibility Genes
by: Giovanna D’Elia, et al.
Published: (2022-09-01)

Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2016 for the Clinical Practice of Hereditary Colorectal Cancer (Translated Version)
by: Hideyuki Ishida, et al.
Published: (2018-05-01)

Prevalence of genetic susceptibility for breast and ovarian cancer in a non-cancer related study population: secondary germline findings from a Swiss single centre cohort
by: Dennis Kraemer, et al.
Published: (2019-08-01)

Prevalence of Pathogenic Germline <i>BRCA1/2</i> Variants and Their Association with Clinical Characteristics in Patients with Epithelial Ovarian Cancer in a Rural Area of Japan
by: Akiko Abe, et al.
Published: (2022-06-01)

Direct letters to relatives at risk of hereditary cancer—study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study)
by: Carolina Hawranek, et al.
Published: (2023-12-01)